Health

NHS England screening programme detects 10,678 lung cancers, majority found at early stages

NHS England’s lung screening programme has detected 10,678 cancers, with more than three-quarters found at stage 1 or 2 after community mobile scans.

#lungcancer, #nhs, #screening, #publichealth

WHO declares PHEIC and Africa CDC issues continental alert for Bundibugyo Ebola in DRC and Uganda

WHO raised its top alert and Africa CDC activated a continental emergency over a Bundibugyo Ebola outbreak affecting eastern DRC and cases in Uganda.

#ebola, #publichealth, #who, #africa

FDA Approves Hepcludex, First U.S. Treatment for Chronic Hepatitis Delta

The FDA cleared Hepcludex (bulevirtide-gmod) for adults with chronic hepatitis D, the first approved U.S. therapy for this serious liver infection.

#hepatitisd, #fda, #gilead, #antivirals

Johns Hopkins–Lancet Commission Releases Report on Health, Conflict and Forced Displacement at World Health Assembly

A Johns Hopkins–Lancet commission publishes a report on health in conflict and forced displacement, launching in Geneva during the World Health Assembly.

#humanitarian, #health, #conflict, #displacement

WHO declares Ebola outbreak in eastern DR Congo and Uganda a global public health emergency

WHO on May 17 declared the Bundibugyo Ebola outbreak in Ituri Province, DR Congo, with confirmed cases in Uganda, a Public Health Emergency of International Concern.

#ebola, #who, #drcongo, #uganda, #publichealth

Texas Children’s Hospital to Stop Puberty Blockers for Minors, Agrees to $10M Settlement With DOJ

DOJ says Texas Children’s will stop puberty blockers and hormones for minors, pay $10M over billing claims and fund a detransition clinic in the first settlement of its probe.

#transgender, #healthcare, #doj, #texas

Eugene Braunwald, Pioneering Cardiologist, Dies at 96

Eugene Braunwald, a trailblazer in cardiology whose research and textbooks reshaped heart care, died April 22 at 96 in Massachusetts.

#cardiology, #obituary, #medicine, #research

UK regulator tightens finasteride warnings and adds precaution for dutasteride over psychiatric and sexual side effects

MHRA updates labels warning finasteride can cause depression, suicidal thoughts and lasting sexual dysfunction; adds precaution for dutasteride.

#health, #mhra, #finasteride, #dutasteride

CDC report details Washington state's fatal H5N5 avian flu case linked to backyard flock

CDC reports the first lab-confirmed human H5N5 infection — a fatal Washington case tied to a backyard flock. No evidence of person-to-person spread; risk low.

#health, #avianinfluenza, #h5n5, #cdc

Study: Galaxy Watch6 biosignals predicted vasovagal fainting up to five minutes — not a device feature

South Korean hospital study found Galaxy Watch6 biosignals predicted vasovagal fainting up to five minutes in tilt‑table tests; Samsung says it's not a device feature.

#wearables, #samsung, #heart-health, #medical-research

Hantavirus Suspected Aboard m/v Hondius Cruise Ship; One Lab-Confirmed Case, Five Suspected, Three Deaths

WHO coordinates response to suspected hantavirus outbreak on m/v Hondius off Cape Verde; one lab-confirmed case, five suspected, three deaths.

#hantavirus, #cruise-ship, #public-health, #who

NHS England rolls out 60-second pembrolizumab injection to cut treatment chair time

NHS England is introducing a subcutaneous form of pembrolizumab (Keytruda) that can be given in about a minute, reducing clinic time for roughly 14,000 patients.

#nhs, #pembrolizumab, #cancer, #immunotherapy

FDA proposes excluding semaglutide, tirzepatide and liraglutide from 503B bulks list

FDA proposes removing semaglutide, tirzepatide and liraglutide from the 503B bulks list, potentially limiting outsourcing facilities' ability to compound GLP‑1 drugs.

#fda, #glp1, #compounding, #semaglutide, #tirzepatide

EMA launches pilot program for ‘breakthrough’ medical devices in EU

EMA launched a pilot to give priority regulatory support to highly innovative Class III and IIb medical devices, testing a potential EU breakthrough pathway.

#medicaldevices, #ema, #healthpolicy, #innovation

FDA approves Otarmeni, first U.S.-cleared gene therapy for genetic hearing loss

FDA approves Otarmeni, the first U.S. gene therapy for OTOF-linked deafness; Regeneron's dual-AAV treatment wins accelerated approval, follow-up data required.

#fda, #regeneron, #genetherapy, #hearingloss, #otology